Olivia Aylon is Associate Principal, Growth Equity in our Toronto office. She is responsible for the origination, evaluation and execution of investment opportunities along with asset management for existing portfolio companies, including Firmex, InvestorCOM, and Rx Drug Mart.
Olivia previously worked at OMERS on the Growth Equity team where she focused on investments in the healthcare, technology, energy and consumer sectors. She was a Director on the Board of a private oil and gas company and an observer to the Board of a private aviation company.
Prior to OMERS, Olivia worked at Deloitte in the Valuations group in Financial Advisory, where she provided valuation services for a variety of purposes, including mergers and acquisitions, board advisory services, corporate restructuring, litigation and financial reporting.
Olivia holds an Honours Business Administration degree from the Ivey Business School at Western University. She also holds the Chartered Business Valuator (CBV) and Chartered Professional Accountant (CPA) designations.